drugset / Trial / NCT04424160

Effects of Platelet Rich Plasma on Endometrium

NCT04424160

NaSingle-groupOpen-labelTreatment

Summary

Intrauterine platelet rich plasma will be injected in the endometrial region via the vaginal route after the cessation of menstrual period. The endometrial thickness will be assessed under ultrasound and hormone replacement will be started. As the endometrial thickness reaches adequate thickness during ultrasound follow-up, embryo transfer will be performed.

Timeline

Start
2020-09-15
Primary completion
2021-04-19
Completion
2021-04-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified Other

Indications